1. Guanine deaminase activities in homogenates and supernatant fractions of liver and brain of rat and mouse were elevated by administration of guanine to the animals. The maximum induction in mouse tissues occurred within 24h and in rat tissues within 48h. 2. Mitochondria ofrat (but not mouse) liver and brain contain an inhibitor of supernatant guanine deaminase, and this was also increased by guanine treatment. 3. Administration of ethionine, cycloheximide or actinomycin D prevented the guanine-dependent increase in deaminase activity and also the increase in mitochondrial inhibitory activity; chloramphenicol suppressed only the latter.
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Earlier investigations from this laboratory showed regulatory behaviour for guanine deaminase in the liver and brain of rats and brain of mice (Sree Kumar et al., 1972 , 1973 , and the inhibition of the guanine deaminase activity in the 15000g supernatant fraction of rat brain and liver (Kumar et al., 1967) , but not of mouse tissues (Sree Kumar et al., 1972) In experiments designed to test the time taken for maximum response to guanine, groups of animals were killed after 24, 48 and 96h, the animals having received one, two and four injections respectively (i.e. death followed 24h after the last injection). In subsequent experiments the homogenates from tissues of mice and rats which received one and two injections respectively (killed at the end of 24 and 48h) were fractionated and the activities of enzyme and inhibitor determined in the subcellular fractions.
Subcellular fractionation
The preparation of homogenates and their separation into subcellular fractions were by the method of Sree Kumar et al. (1972) , with the differences that the 'heavy' and 'light' mitochondrial fractions were sedimented together from the postnuclear (700g, 10min) supernatant at 15000g for 60min, the particulate fractions were washed four times instead of three and the volumes of medium used for washing were increased 6-fold for the nuclear fraction and 3-fold for the mitochondrial fraction. Under these modified conditions of isolation, the nuclear and mitochondrial fractions of liver and brain were devoid of guanine deaminase activity, both in the rat and the mouse.
Enzyme assay
For determination of guanine deaminase activity in homogenates or subcellular fractions, the assay system (b) described by Sree Kumar et al. (1972) was used. To avoid any interference by xanthine oxidase 10juM-allopurinol, a specific and potent inhibitor of xanthine oxidase (Iwata et al., 1969) , was incorporated into all assays except those for mouse liver. The low guanine deaminase activity in mouse liver necessitated the use of large samples of homogenates and-subcellular fractions in the assay system, with the result that the blank absorption was high and supplementation with allopurinol would have rendered the assay insensitive by increasing the absorption.
Inhibitor assay
To test the inhibitory activity of the mitochondrial fractions towards the supernatant enzyme, the two fractions were mixed in the same proportions as in the unfractionated homogenate and the mixture was analysed for residual enzyme activity. Under these conditions about 25-35% inhibition was caused, and the measured 'units' of inhibition (see below) were independent of the enzyme concentration. Allopurinol was not used because of the high absorption.
Test for 'latent' inhibitor activity
To test for 'latent' inhibitory activity in mitochondrial fractions, the pooled mitochondrial material ofeach group was frozen overnight at -1 8°C, thawed, ground in a VirTis homogenizer and Triton X-100 was added to give 1 % (v/v). The mixtures were left in the cold for 1 h and then centrifuged for h at 15000g. The supernatants (which contained about 50% of the protein in the mitochondrial fraction) were analysed forinhibitory activity; the residues were devoid of activity.
Protein determination
The protein content of homogenates and subcellular fractions was determined by the method of Lowry et al. (1951) , with bovine serum albumin (Sigma, crystallized and freeze-dried) as standard.
Expression of results
One unit of guanine deaminase deaminated 1 ,mol of guanine at 30°C in 15min under the assay conditions and a unit of inhibitor caused 50% inhibition of 1 unit of enzyme activity under the above conditions of enzyme assay. Enzyme activity and 'overt' inhibitor activity were calculated as units/g equivalent of fresh tissue and as units/mg of protein in the fraction. The protein content of liver or brain were not significantly altered as a result of administration of guanine or guanine plus an inhibitor of protein synthesis. The 'latent' activity of the mitochondrial inhibitor was obtained by subtracting the 'overt' inhibitory activity in the mitochondrial fraction from the total activity of the extract of the Triton-treated fraction. The activity was calculated as units/g equivalent of tissue and as units/mg of protein in the mitochondrial fraction from which the extract for activity determination was obtained.
The results, except when the pooled mitochondrial fractions were used for determination of latent inhibitor activity, were subjected to statistical evaluation and the data presented as the mean ±S.D. of the observations. The statistical significance of the data calculated on the basis of protein was evaluated by Student's t test.
Results
Influence of treatment with guanine and inhibitors of protein synthesis on enzyme activities: analyses of homogenates Mice. Administration of a single dose of guanine resulted in about 65 % increase (P<0.001) in the activity of guanine deaminase in liver at the end of 24h; in brain there was a 40 % (P <0.001) rise. On treatment for longer periods, the enzyme activity in brain returned to the control value in animals killed at the end of 96h, but that in liver declined only slightly and remained 45-50% higher (P<0.001) than in controls. Administration of ethionine together with the guanine blocked the increases in activity of guanine deaminase in both liver and brain.
Rats. A single dose of guanine elevated the activity of enzyme by 30% (P<0.05) in liver and 16% (P <0.05) in brain. At the end of 48h, after two doses of guanine, there were 50% and 40% rises (P<0.001) in enzyme activity in liver and brain respectively. Thereafter there was a decline in both tissues, but the values were still higher than in the controls. As in mice, administration of ethionine prevented the increase in enzyme activity in both liver and brain.
Influence of guanine treatment on guanine deaminase and inhibitory activity studied in subcellular fractions Studies on subcellular fractions were conducted with the tissue obtained from mice and rats treated respectively for 24 and 48h, since the maximum response to guanine occurred during this period.
Guanine deaminase. Theresults obtained forenzyme activity in homogenates and the corresponding 15000g supernatant fractions are presented in Table 1 .
Inhibitory activity associated with mitochondria. The mitochondrial fraction from mouse tissues did not contain 'overt' or 'latent' inhibitory activity towards the superantant guanine deaminase.
In rat liver, the 'overt' inhibitory activity of the mitochondrial fraction in guanine- calculated on the basis of protein and tissue weight respectively. The brain mitochondrial fraction, however, showed increases of 21 % (P<0.01) and 29% (P<0.01) respectively. In animals which received ethionine together with guanine, the 'overt' mitochondrial inhibitory activity in liver and brain was the same as in animals receiving 0.9% NaCl only. The 'latent' inhibitory activities in liver and brain mitochondrial fractions from animals receiving guanine or guanine plus ethionine were nearly the same as in the corresponding fractions from control animals.
Effect of cycloheximide, chloramphenicol and actinomycin D on guanine deaminase and inhibitor activity in vivo in rat liver Like ethionine, cycloheximide given with guanine abolished the guanine-dependent increase in deaminase activity of liver homogenates or supernatant fraction and also prevented the increase in 'overt' mitochondrial inhibitory power. Chloramphenicol only slightly decreased the guanine-induced increase in deaminase activity, but did abolish the increase in inhibitory power.
To test whether RNA synthesis was essential for the increase in enzyme activity caused by guanine treatment, rats were given guanine plus actinomycin D and killed after 48h, as were appropriate control animals. The administration of actinomycin D prevented the increase in enzyme activity, and also caused the disappearance of all 'overt' mitochondrial inhibitory activity. However, the 'latent' inhibitory activity was more than doubled by actinomycin D treatment, although the total inhibitory activity ('latent' plus 'overt') was decreased by about 40 %.
Ethionine, cycloheximide, chloramphenicol and actinomycin D, added directly to the assay systems, were all without effect on guanine deaminase or the mitochondrial inhibitory activity.
Discussion
Previous reports from this laboratory (Sree Kumar et al., 1973) had established that guanine deaminases in rat liver and brain, and also mouse brain, showed regulatory properties. The present data show that the deaminase activity in liver and brain of rats and mice is increased by administration of guanine in vivo. The results with inhibitor suggest that this increase is dependent on RNA and protein synthesis.
In rats, but not mice, the 'overt' inhibitory activity in the mitochondrial fraction of both liver and brain was also increased by guanine treatment, suggesting a possible regulatory role for the inhibitor. This increase was also blocked by the inhibitors of protein synthesis tested. Chloramphenicol, which did not prevent the increase in deaminase activity, did block the increase in inhibitory activity, suggesting that mitochondrial protein synthesis might be involved in this case.
